Twist Bioscience Corp (TWST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
(Values in U.S. thousands)
| 09-2025 | 09-2024 | 09-2023 | 09-2022 | 09-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -77,670 | -208,726 | -204,618 | -217,863 | -152,098 |
| Depreciation Amortization | 24,853 | 31,432 | 29,310 | 16,514 | 9,750 |
| Accounts receivable | -22,382 | 8,444 | -4,320 | -9,622 | -2,202 |
| Accounts payable and accrued liabilities | 9,332 | -11,805 | -2,508 | 7,383 | 8,542 |
| Other Working Capital | -12,606 | 15,411 | -1,009 | -5,356 | -9,381 |
| Other Operating Activity | 30,845 | 101,150 | 40,671 | 84,559 | 33,145 |
| Operating Cash Flow | $-47,628 | $-64,094 | $-142,474 | $-124,385 | $-112,244 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -28,004 | -5,076 | -27,779 | -101,857 | -27,061 |
| Net Acquisitions | 2,500 | N/A | N/A | -13,915 | -483 |
| Purchase Of Investment | -49,393 | -51,905 | -76,345 | -217,639 | -58,795 |
| Sale Of Investment | 50,135 | 53,910 | 154,736 | 100,481 | 242,494 |
| Investing Cash Flow | $-24,762 | $-3,071 | $50,612 | $-232,930 | $156,155 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 15,000 | 0 | 0 | N/A | N/A |
| Debt Repayment | N/A | N/A | N/A | -1,558 | -3,333 |
| Common Stock Issued | 13,556 | 10,865 | 5,316 | 279,846 | 343,364 |
| Common Stock Repurchased | -16 | -3,975 | -4,405 | -7,754 | -10,849 |
| Financing Cash Flow | $28,540 | $6,890 | $911 | $270,534 | $329,182 |
| Exchange Rate Effect | 143 | 126 | -27 | -319 | 20 |
| Beginning Cash Position | 229,132 | 289,281 | 380,259 | 467,359 | 94,246 |
| End Cash Position | 185,425 | 229,132 | 289,281 | 380,259 | 467,359 |
| Net Cash Flow | $-43,707 | $-60,149 | $-90,978 | $-87,100 | $373,113 |
| Free Cash Flow | |||||
| Operating Cash Flow | -47,628 | -64,094 | -142,474 | -124,385 | -112,244 |
| Capital Expenditure | -28,004 | -5,076 | -27,779 | -101,857 | -27,061 |
| Free Cash Flow | -75,632 | -69,170 | -170,253 | -226,242 | -139,305 |